Back to
WELLS FARGO & COMPANY/MN
INKT6 quarters
Position history for
WELLS FARGO & COMPANY/MN's holdings in MINK THERAPEUTICS INC
Yes. Wells Fargo holds 2 shares of INKT (Mink Therapeutics), worth $23, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$23
Current Shares
2
Total Value Change
-$7,304
Total Shares Change
-846
Quarter-by-Quarter History
Other major holders of INKT: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, DnB Asset Management AS